Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase IIIb, Open-Label, Multicenter, Observational, Non-Comparative Study Assessing Longterm Efficacy And Safety Of Somatropin In Adult Patients With Growth Hormone Deficiency (GHD)

Next Previous
X
Search
Trial Profile

A Phase IIIb, Open-Label, Multicenter, Observational, Non-Comparative Study Assessing Longterm Efficacy And Safety Of Somatropin In Adult Patients With Growth Hormone Deficiency (GHD)

Status: Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 19 Apr 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Somatropin (Primary)
  • Indications Somatotropin deficiency
  • Focus Therapeutic Use

    • Most Recent Events

    • 19 Apr 2017 New trial record
    • 04 Apr 2017 Results of interim analysis (up to 24 months treatment) assessing effect of somatropin on body composition and bone mineral density, presented at The 99th Annual Meeting of the Endocrine Society.
    • 04 Apr 2017 Interim results of data up to 24 months of treatment, presented at The 99th Annual Meeting of the Endocrine Society

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top